Publications | Page 4 | Cervo Brain Research Centre

Export 18 results:

Filters: Author is Marie-France Demers [Clear All Filters]

2018

M-A Roy, Vallières, C., Lehoux, C., Leclerc, L. - D., Demers, M. - F., and Achim, A., “More intensive probing increases the detection of social anxiety disorders in schizophrenia.”, Psychiatry Res, vol. 268, pp. 358-360, 2018.

M-A Roy, Demers, M. - F., and Achim, A., “Social anxiety disorder in schizophrenia: a neglected, yet potentially important comorbidity.”, J Psychiatry Neurosci, vol. 43, no. 4, pp. 287-288, 2018.

2017

J. - D. Carrier, Blais, L., Cohen, A., Courteau, J., Roberge, P., Larouche, A., Grignon, S., Fleury, M. - J., Lesage, A., Demers, M. - F., M-A Roy, Delorme, A., and Vanasse, A., “[Initiating an antipsychotic drug treatment for schizophrenia: the situation in Quebec, Canada, from 1998 to 2006].”, Sante Ment Que, vol. 42, no. 1, pp. 85-103, 2017.

P. D. Vincent, Demers, M. - F., Doyon-Kemp, V., Duchesneau, J., Halme, A., and Masson, V., “One year mirror-image study using paliperidone palmitate for relapse prevention of schizophrenia in four university hospitals in Canada.”, Schizophr Res, vol. 185, pp. 96-100, 2017.

2016

A. Vanasse, Blais, L., Courteau, J., Cohen, A. A., Roberge, P., Larouche, A., Grignon, S., Fleury, M. - J., Lesage, A., Demers, M. - F., M-A Roy, Carrier, J. - D., and Delorme, A., “Comparative effectiveness and safety of antipsychotic drugs in schizophrenia treatment: a real-world observational study.”, Acta Psychiatr Scand, vol. 134, no. 5, pp. 374-384, 2016.

2015

M-A Roy, Achim, A., Vallières, C., Labbé, A., Mérette, C., Maziade, M., Demers, M. - F., and Bouchard, R. - H., “Comorbidity between anxiety disorders and recent-onset psychotic disorders.”, Schizophr Res, vol. 166, no. 1-3, pp. 353-4, 2015.

2008

S. Potvin, Stip, E., Lipp, O., M-A Roy, Demers, M. - F., Bouchard, R. - H., and Gendron, A., “Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.”, Am J Drug Alcohol Abuse, vol. 34, no. 1, pp. 75-82, 2008.

S. Potvin, Kouassi, E., Lipp, O., Bouchard, R. - H., M-A Roy, Demers, M. - F., Gendron, A., Astarita, G., Piomelli, D., and Stip, E., “Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy.”, J Psychopharmacol, vol. 22, no. 3, pp. 262-9, 2008.

2007

S. L'Heureux, Nicole, L., Abdel-Baki, A., M-A Roy, Gingras, N., and Demers, M. - F., “[Improving detection and treatment of early psychosis in Québec: the Quebec association of early psychosis (l'Association québécoise des programmes pour premiers épisodes psychotiques, AQPPEP), sees to it].”, Sante Ment Que, vol. 32, no. 1, pp. 299-315, 2007.

2006

S. Potvin, Stip, E., Lipp, O., Elie, R., Mancini-Marië, A., Demers, M. - F., M-A Roy, Bouchard, R. - H., and Gendron, A., “Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial.”, Curr Med Res Opin, vol. 22, no. 7, pp. 1277-85, 2006.

2004

N. Alméras, Després, J. - P., Villeneuve, J., Demers, M. - F., M-A Roy, Cadrin, C., Mottard, J. - P., and Bouchard, R. - H., “Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics.”, J Clin Psychiatry, vol. 65, no. 4, pp. 557-64, 2004.

2002

M. - F. Demers, “First person account: Susan's cello.”, Schizophr Bull, vol. 28, no. 1, pp. 187-9, 2002.

2001

R. H. Bouchard, Demers, M. - F., Simoneau, I., Alméras, N., Villeneuve, J., Mottard, J. P., Cadrin, C., Lemieux, I., and Després, J. P., “Atypical antipsychotics and cardiovascular risk in schizophrenic patients.”, J Clin Psychopharmacol, vol. 21, no. 1, pp. 110-1, 2001.

P. Rouillard and Demers, M. - F., “[Psychosis and addiction: the experience of the Polyclinique Sainte-Anne.].”, Sante Ment Que, vol. 26, no. 2, pp. 62-91, 2001.

2000

R. H. Bouchard, Mérette, C., Pourcher, E., Demers, M. - F., Villeneuve, J., Roy-Gagnon, M. H., Gauthier, Y., Cliche, D., Labelle, A., Filteau, M. J., M-A Roy, and Maziade, M., “Longitudinal comparative study of risperidone and conventional neuroleptics for treating patients with schizophrenia. The Quebec Schizophrenia Study Group.”, J Clin Psychopharmacol, vol. 20, no. 3, pp. 295-304, 2000.

I. Simoneau, Villeneuve, J., Demers, M. - F., and Bouchard, R. H., “[Schizophrenia and psychoactive drug abuse: dual diagnostic problem].”, Can J Psychiatry, vol. 45, no. 6, pp. 572-3, 2000.

M. J. Filteau, Leblanc, J., Lefrançoise, S., and Demers, M. - F., “Visual and auditory hallucinations with the association of bupropion and valproate.”, Can J Psychiatry, vol. 45, no. 2, pp. 198-9, 2000.

1998

J. P. Bonin, Lesage, A., Ricard, N., Demers, M. - F., Morissette, R., and Benoit, D., “Empowering the staff in long-stay wards.”, Can J Psychiatry, vol. 43, no. 10, pp. 1054-5, 1998.

Funding / Support / Partners

© Gouvernement du Québec